Panbela Therapeutics EV/EBIT
Mi az Panbela Therapeutics EV/EBIT?
A EV/EBIT az Panbela Therapeutics Inc. - N/A
Mi a EV/EBIT meghatározása?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT a Health Care szektor a NASDAQ-on cégekben a Panbela Therapeutics -hoz képest
Mit csinál Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
ev/ebit -hoz hasonló cégek Panbela Therapeutics
- Radha Madhav nak EV/EBIT N/A van
- Acasti Pharma Inc nak EV/EBIT N/A van
- Akers Biosciences Inc nak EV/EBIT N/A van
- Agios Pharmaceuticals Inc nak EV/EBIT N/A van
- Generation Bio Co nak EV/EBIT N/A van
- Purple Biotech nak EV/EBIT N/A van
- Panbela Therapeutics nak EV/EBIT N/A van
- Continental Materials nak EV/EBIT N/A van
- GlycoMimetics Inc nak EV/EBIT N/A van
- Veritas Pharma nak EV/EBIT N/A van
- Impac Mortgage nak EV/EBIT N/A van
- Canterra Minerals nak EV/EBIT N/A van
- Kinnate Biopharma nak EV/EBIT N/A van